世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Factor VIII Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z05433
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、第VIII因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第VIII因子欠乏症治療の種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・第VIII因子欠乏症治療の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Takeda、Bayer HealthCare、CSL、Grifols、Novo Nordisk、F. Hoffmann-La Roche、Kedrion、Octapharma、Biogen Idec、BioMarin Pharmaceutical、Sangamo Therapeutics、Spark Therapeutics、Swedish Orphan Biovitrum、Uniqure NV、Amarna Therapeutics、Dimension Therapeutics
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療
・用途別分析2016年-2026年：病院、診療所、その他
・第VIII因子欠乏症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・第VIII因子欠乏症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・第VIII因子欠乏症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・第VIII因子欠乏症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・第VIII因子欠乏症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Factor VIII Deficiency Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Factor VIII Deficiency Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Factor VIII Deficiency Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment

Market segment by Application, can be divided into
Hospitals
Clinics
Other

Market segment by players, this report covers
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
1.2 Classification of Factor VIII Deficiency Treatment by Type
1.2.1 Overview: Global Factor VIII Deficiency Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2020
1.2.3 Hemophilia A Drugs
1.2.4 Hemophilia A Inhibitors Treatment
1.2.5 Von Willebrand Disease Treatment
1.3 Global Factor VIII Deficiency Treatment Market by Application
1.3.1 Overview: Global Factor VIII Deficiency Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor VIII Deficiency Treatment Market Size & Forecast
1.5 Global Factor VIII Deficiency Treatment Market Size and Forecast by Region
1.5.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Factor VIII Deficiency Treatment Market Size by Region, (2016-2021)
1.5.3 North America Factor VIII Deficiency Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Factor VIII Deficiency Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Factor VIII Deficiency Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Factor VIII Deficiency Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Factor VIII Deficiency Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Factor VIII Deficiency Treatment Market Drivers
1.6.2 Factor VIII Deficiency Treatment Market Restraints
1.6.3 Factor VIII Deficiency Treatment Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Factor VIII Deficiency Treatment Product and Solutions
2.1.4 Pfizer Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Factor VIII Deficiency Treatment Product and Solutions
2.2.4 Takeda Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Takeda Recent Developments and Future Plans
2.3 Bayer HealthCare
2.3.1 Bayer HealthCare Details
2.3.2 Bayer HealthCare Major Business
2.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Product and Solutions
2.3.4 Bayer HealthCare Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer HealthCare Recent Developments and Future Plans
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Factor VIII Deficiency Treatment Product and Solutions
2.4.4 CSL Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 CSL Recent Developments and Future Plans
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Factor VIII Deficiency Treatment Product and Solutions
2.5.4 Grifols Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Grifols Recent Developments and Future Plans
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Factor VIII Deficiency Treatment Product and Solutions
2.6.4 Novo Nordisk Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novo Nordisk Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product and Solutions
2.7.4 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Factor VIII Deficiency Treatment Product and Solutions
2.8.4 Kedrion Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kedrion Recent Developments and Future Plans
2.9 Octapharma
2.9.1 Octapharma Details
2.9.2 Octapharma Major Business
2.9.3 Octapharma Factor VIII Deficiency Treatment Product and Solutions
2.9.4 Octapharma Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Octapharma Recent Developments and Future Plans
2.10 Biogen Idec
2.10.1 Biogen Idec Details
2.10.2 Biogen Idec Major Business
2.10.3 Biogen Idec Factor VIII Deficiency Treatment Product and Solutions
2.10.4 Biogen Idec Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Biogen Idec Recent Developments and Future Plans
2.11 BioMarin Pharmaceutical
2.11.1 BioMarin Pharmaceutical Details
2.11.2 BioMarin Pharmaceutical Major Business
2.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Solutions
2.11.4 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BioMarin Pharmaceutical Recent Developments and Future Plans
2.12 Sangamo Therapeutics
2.12.1 Sangamo Therapeutics Details
2.12.2 Sangamo Therapeutics Major Business
2.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.12.4 Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Sangamo Therapeutics Recent Developments and Future Plans
2.13 Spark Therapeutics
2.13.1 Spark Therapeutics Details
2.13.2 Spark Therapeutics Major Business
2.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.13.4 Spark Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Spark Therapeutics Recent Developments and Future Plans
2.14 Swedish Orphan Biovitrum
2.14.1 Swedish Orphan Biovitrum Details
2.14.2 Swedish Orphan Biovitrum Major Business
2.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product and Solutions
2.14.4 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
2.15 Uniqure NV
2.15.1 Uniqure NV Details
2.15.2 Uniqure NV Major Business
2.15.3 Uniqure NV Factor VIII Deficiency Treatment Product and Solutions
2.15.4 Uniqure NV Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Uniqure NV Recent Developments and Future Plans
2.16 Amarna Therapeutics
2.16.1 Amarna Therapeutics Details
2.16.2 Amarna Therapeutics Major Business
2.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.16.4 Amarna Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Amarna Therapeutics Recent Developments and Future Plans
2.17 Dimension Therapeutics
2.17.1 Dimension Therapeutics Details
2.17.2 Dimension Therapeutics Major Business
2.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.17.4 Dimension Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Dimension Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Factor VIII Deficiency Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Factor VIII Deficiency Treatment Players Market Share
3.2.2 Top 10 Factor VIII Deficiency Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Factor VIII Deficiency Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Factor VIII Deficiency Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2016-2021)
5.2 Factor VIII Deficiency Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Factor VIII Deficiency Treatment Revenue by Type (2016-2026)
6.2 North America Factor VIII Deficiency Treatment Revenue by Application (2016-2026)
6.3 North America Factor VIII Deficiency Treatment Market Size by Country
6.3.1 North America Factor VIII Deficiency Treatment Revenue by Country (2016-2026)
6.3.2 United States Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Factor VIII Deficiency Treatment Revenue by Type (2016-2026)
7.2 Europe Factor VIII Deficiency Treatment Revenue by Application (2016-2026)
7.3 Europe Factor VIII Deficiency Treatment Market Size by Country
7.3.1 Europe Factor VIII Deficiency Treatment Revenue by Country (2016-2026)
7.3.2 Germany Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
7.3.3 France Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region
8.3.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2016-2026)
8.3.2 China Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8.3.5 India Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Factor VIII Deficiency Treatment Revenue by Type (2016-2026)
9.2 South America Factor VIII Deficiency Treatment Revenue by Application (2016-2026)
9.3 South America Factor VIII Deficiency Treatment Market Size by Country
9.3.1 South America Factor VIII Deficiency Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country
10.3.1 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Factor VIII Deficiency Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Factor VIII Deficiency Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Factor VIII Deficiency Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Factor VIII Deficiency Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Factor VIII Deficiency Treatment Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Factor VIII Deficiency Treatment Product and Solutions
Table 9. Pfizer Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Takeda Corporate Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Factor VIII Deficiency Treatment Product and Solutions
Table 13. Takeda Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer HealthCare Corporate Information, Head Office, and Major Competitors
Table 15. Bayer HealthCare Major Business
Table 16. Bayer HealthCare Factor VIII Deficiency Treatment Product and Solutions
Table 17. Bayer HealthCare Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. CSL Corporate Information, Head Office, and Major Competitors
Table 19. CSL Major Business
Table 20. CSL Factor VIII Deficiency Treatment Product and Solutions
Table 21. CSL Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Grifols Corporate Information, Head Office, and Major Competitors
Table 23. Grifols Major Business
Table 24. Grifols Factor VIII Deficiency Treatment Product and Solutions
Table 25. Grifols Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 27. Novo Nordisk Major Business
Table 28. Novo Nordisk Factor VIII Deficiency Treatment Product and Solutions
Table 29. Novo Nordisk Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Major Business
Table 32. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product and Solutions
Table 33. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kedrion Corporate Information, Head Office, and Major Competitors
Table 35. Kedrion Major Business
Table 36. Kedrion Factor VIII Deficiency Treatment Product and Solutions
Table 37. Kedrion Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Octapharma Corporate Information, Head Office, and Major Competitors
Table 39. Octapharma Major Business
Table 40. Octapharma Factor VIII Deficiency Treatment Product and Solutions
Table 41. Octapharma Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 43. Biogen Idec Major Business
Table 44. Biogen Idec Factor VIII Deficiency Treatment Product and Solutions
Table 45. Biogen Idec Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BioMarin Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. BioMarin Pharmaceutical Major Business
Table 48. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Solutions
Table 49. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Sangamo Therapeutics Major Business
Table 52. Sangamo Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 53. Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Spark Therapeutics Major Business
Table 56. Spark Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 57. Spark Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Swedish Orphan Biovitrum Corporate Information, Head Office, and Major Competitors
Table 59. Swedish Orphan Biovitrum Major Business
Table 60. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product and Solutions
Table 61. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Uniqure NV Corporate Information, Head Office, and Major Competitors
Table 63. Uniqure NV Major Business
Table 64. Uniqure NV Factor VIII Deficiency Treatment Product and Solutions
Table 65. Uniqure NV Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Amarna Therapeutics Corporate Information, Head Office, and Major Competitors
Table 67. Amarna Therapeutics Major Business
Table 68. Amarna Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 69. Amarna Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Dimension Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Dimension Therapeutics Major Business
Table 72. Dimension Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 73. Dimension Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Players (2019-2021)
Table 75. Global Factor VIII Deficiency Treatment Revenue Share by Players (2019-2021)
Table 76. Breakdown of Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Factor VIII Deficiency Treatment Players Head Office, Products and Services Provided
Table 78. Factor VIII Deficiency Treatment Mergers & Acquisitions in the Past Five Years
Table 79. Factor VIII Deficiency Treatment New Entrants and Expansion Plans
Table 80. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Type (2016-2021)
Table 81. Global Factor VIII Deficiency Treatment Revenue Share by Type (2016-2021)
Table 82. Global Factor VIII Deficiency Treatment Revenue Forecast by Type (2021-2026)
Table 83. Global Factor VIII Deficiency Treatment Revenue by Application (2016-2021)
Table 84. Global Factor VIII Deficiency Treatment Revenue Forecast by Application (2021-2026)
Table 85. North America Factor VIII Deficiency Treatment Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Factor VIII Deficiency Treatment Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Factor VIII Deficiency Treatment Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Factor VIII Deficiency Treatment Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Factor VIII Deficiency Treatment Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Factor VIII Deficiency Treatment Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Factor VIII Deficiency Treatment Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Factor VIII Deficiency Treatment Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Factor VIII Deficiency Treatment Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Factor VIII Deficiency Treatment Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Factor VIII Deficiency Treatment Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Factor VIII Deficiency Treatment Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Factor VIII Deficiency Treatment Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Factor VIII Deficiency Treatment Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Factor VIII Deficiency Treatment Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Factor VIII Deficiency Treatment Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Factor VIII Deficiency Treatment Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Factor VIII Deficiency Treatment Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Factor VIII Deficiency Treatment Picture
Figure 2. Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2020
Figure 3. Hemophilia A Drugs
Figure 4. Hemophilia A Inhibitors Treatment
Figure 5. Von Willebrand Disease Treatment
Figure 6. Factor VIII Deficiency Treatment Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Factor VIII Deficiency Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Factor VIII Deficiency Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Factor VIII Deficiency Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Factor VIII Deficiency Treatment Revenue Market Share by Region in 2020
Figure 14. North America Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Factor VIII Deficiency Treatment Market Drivers
Figure 19. Factor VIII Deficiency Treatment Market Restraints
Figure 20. Factor VIII Deficiency Treatment Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. Takeda Recent Developments and Future Plans
Figure 23. Bayer HealthCare Recent Developments and Future Plans
Figure 24. CSL Recent Developments and Future Plans
Figure 25. Grifols Recent Developments and Future Plans
Figure 26. Novo Nordisk Recent Developments and Future Plans
Figure 27. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 28. Kedrion Recent Developments and Future Plans
Figure 29. Octapharma Recent Developments and Future Plans
Figure 30. Biogen Idec Recent Developments and Future Plans
Figure 31. BioMarin Pharmaceutical Recent Developments and Future Plans
Figure 32. Sangamo Therapeutics Recent Developments and Future Plans
Figure 33. Spark Therapeutics Recent Developments and Future Plans
Figure 34. Swedish Orphan Biovitrum Recent Developments and Future Plans
Figure 35. Uniqure NV Recent Developments and Future Plans
Figure 36. Amarna Therapeutics Recent Developments and Future Plans
Figure 37. Dimension Therapeutics Recent Developments and Future Plans
Figure 39. Global Factor VIII Deficiency Treatment Revenue Share by Players in 2020
Figure 40. Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Factor VIII Deficiency Treatment Revenue Market Share in 2020
Figure 42. Global Top 10 Players Factor VIII Deficiency Treatment Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Factor VIII Deficiency Treatment Revenue Share by Type in 2020
Figure 45. Global Factor VIII Deficiency Treatment Market Share Forecast by Type (2021-2026)
Figure 46. Global Factor VIII Deficiency Treatment Revenue Share by Application in 2020
Figure 47. Global Factor VIII Deficiency Treatment Market Share Forecast by Application (2021-2026)
Figure 48. North America Factor VIII Deficiency Treatment Sales Market Share by Type (2016-2026)
Figure 49. North America Factor VIII Deficiency Treatment Sales Market Share by Application (2016-2026)
Figure 50. North America Factor VIII Deficiency Treatment Revenue Market Share by Country (2016-2026)
Figure 51. United States Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Factor VIII Deficiency Treatment Sales Market Share by Type (2016-2026)
Figure 55. Europe Factor VIII Deficiency Treatment Sales Market Share by Application (2016-2026)
Figure 56. Europe Factor VIII Deficiency Treatment Revenue Market Share by Country (2016-2026)
Figure 57. Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Factor VIII Deficiency Treatment Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Factor VIII Deficiency Treatment Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Region (2016-2026)
Figure 65. China Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Factor VIII Deficiency Treatment Sales Market Share by Type (2016-2026)
Figure 72. South America Factor VIII Deficiency Treatment Sales Market Share by Application (2016-2026)
Figure 73. South America Factor VIII Deficiency Treatment Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Factor VIII Deficiency Treatment Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Factor VIII Deficiency Treatment Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source

以下、関連資料のご紹介

世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2310 2021年4月 128Pages
QYResearch社発行の本調査資料では、第VIII因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北...

世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Factor IX Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z05432 2021年4月 100Pages
当調査資料では、第IX因子欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。第IX因子欠乏症治療の種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のα1-アンチトリプシン欠乏症治療市場 2021：企業別、地域別、種類・用途別

Global Alpha 1 Antitrypsin Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00720 2021年4月 128Pages
当調査資料では、α1-アンチトリプシン欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。α1-アンチトリプシン欠乏症治療の種類別市場規模（増強療法、気管支拡張薬、コルチコステロイド、酸素療法）、用途別市場規模（病院、専門診療所、薬局）、地域別市...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のヒト凝固因子Ⅷ市場 2021：企業別、地域別、種類・用途別

Global Human Coagulation Factor Ⅷ Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z07253 2021年4月 104Pages
当調査資料では、ヒト凝固因子Ⅷのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト凝固因子Ⅷの種類別市場規模（リコンビナント第VIII因子、ヒューマン第VIII因子）、用途別市場規模（血友病A、出血性出血性疾患）、地域別市場規模（北米、アメリカ、ヨーロ...

世界のアルファ-アンチトリプシン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0255 2021年4月 133Pages
QYResearch社発行の本調査資料では、アルファ-アンチトリプシン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）、用途別市場規模（クリニック、病院、そ...

世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Vitamin D Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5957 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビタミンD欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンD2、ビタミンD3）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2639 2021年4月 90Pages
QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、ア...

世界のチロシンヒドロキシラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5773 2021年4月 91Pages
QYResearch社発行の本調査資料では、チロシンヒドロキシラーゼ欠損症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、言語療法、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…
世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vitamin D Deficiency Treatment Market The global Vitamin D Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…